JPMorgan Chase & Co. (NYSE: JPM) today announced its plan to acquire InstaMed, a leading U.S. healthcare technology company that specializes in he
JPMorgan Chase & Co. (NYSE: JPM) announced its plan to acquire InstaMed to help expand their capabilities in healthcare payments. InstaMed is a leading U.S. healthcare technology company, which provides a platform that connects consumers, providers and payers for every healthcare payment transaction. The acquisition will offer an end-to-end healthcare payments solution to healthcare providers, payers and consumers. According to CNBC, the acquisition is valued more than $500 million, marking the Company’s biggest buy since 2008.